Technical Analysis for GUD - Knight Therapeutics Inc.

Grade Last Price % Change Price Change
F 5.260 2.14% 0.110
GUD closed up 2.14 percent on Friday, November 8, 2024, on 2.68 times normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Earnings Movers Other 0.00%
Below Lower BB Weakness 0.00%
Fell Below 20 DMA Bearish 2.14%
Fell Below 200 DMA Bearish 2.14%
MACD Bearish Signal Line Cross Bearish 2.14%
Expansion Breakdown Bearish Swing Setup 2.14%
Expansion Pivot Sell Setup Bearish Swing Setup 2.14%
Volume Surge Other 2.14%
Wide Range Bar Range Expansion 2.14%
Earnings Movers Other 2.14%

   Recent Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Knight Therapeutics Inc. Description

Knight Therapeutics Inc is a Canada-based pharmaceutical company. The Company is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products, consumer health products and medical devices in Canada and select international markets. It finances other life sciences companies in Canada and internationally. Its prescription pharmaceuticals and medical devices in various stages of development include Impavido, AzaSite, ATryn, Photofrin, ILUVIEN, TULSA-PRO, PROBUPHINE, Advaxis Family of Products, Ember Family of Products, NeurAxon Family of Products, Antibe Family of Products, Blood Factor Products and VEWS Vascular Early Warning System. In addition, the Company also has a portfolio of branded consumer health products, including Neuragen, Flat Tummy Tea, FOCUSFactor, FLEXISEQ, SEQuaderma, HandMD, UrgentRx, Laboratoire Dr. Renaud, Premiology and Pro-Derm.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Marketing Pharma Pharmaceutical Labor Science Pharmaceuticals Life Sciences Pharmaceutical Products Pharmaceutical Industry Medical Devices Pharmaceutical Sciences Consumer Health Products Pharmaceutical Industry In China

Is GUD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.23
52 Week Low 4.61
Average Volume 76,876
200-Day Moving Average 5.672
50-Day Moving Average 5.755
20-Day Moving Average 5.602
10-Day Moving Average 5.573
Average True Range 0.161
RSI (14) 34.21
ADX 20.97
+DI 12.502
-DI 33.918
Chandelier Exit (Long, 3 ATRs) 5.466
Chandelier Exit (Short, 3 ATRs) 5.584
Upper Bollinger Bands 5.888
Lower Bollinger Band 5.316
Percent B (%b) -0.1
BandWidth 10.225
MACD Line -0.091
MACD Signal Line -0.060
MACD Histogram -0.0312
Fundamentals Value
Market Cap 685.62 Million
Num Shares 130 Million
EPS 0.20
Price-to-Earnings (P/E) Ratio 26.43
Price-to-Sales 4.06
Price-to-Book 0.82
PEG Ratio 2856.67
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.530
Resistance 3 (R3) 5.507 5.393 5.485
Resistance 2 (R2) 5.393 5.325 5.405 5.470
Resistance 1 (R1) 5.327 5.282 5.360 5.350 5.455
Pivot Point 5.213 5.213 5.230 5.225 5.213
Support 1 (S1) 5.147 5.145 5.180 5.170 5.065
Support 2 (S2) 5.033 5.102 5.045 5.050
Support 3 (S3) 4.967 5.033 5.035
Support 4 (S4) 4.990